Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CHD1 Products

(Chromodomain Helicase DNA Binding Protein 1 (CHD1))

Categories

The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. [provided by RefSeq, Jul 2008].

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Featured CHD1 Categories

CHD1 Antibodies

High quality antibodies with extensive validation data.

Recommended CHD1 Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application WB, IHC
Validations
  • (5)
Cat. No. ABIN6138500
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application ELISA, IHC, ChIP
Validations
  • (3)
Cat. No. ABIN7147714
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF
Validations
  • (3)
Cat. No. ABIN514372
Quantity 100 μg
Datasheet Datasheet

Recommended CHD1 ELISA Kits

Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
Cat. No. ABIN6202835
Quantity 96 tests
Datasheet Datasheet

Recommended CHD1 Proteins

Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Source Wheat germ
Validations
  • (1)
Cat. No. ABIN1349288
Quantity 10 μg
Datasheet Datasheet

Latest Publications for our CHD1 products

Skene, Hernandez, Groudine, Henikoff: "The nucleosomal barrier to promoter escape by RNA polymerase II is overcome by the chromatin remodeler Chd1." in: eLife, Vol. 3, pp. e02042, (2014) (PubMed).

Burkhardt, Fuchs, Krohn, Masser, Mader, Kluth, Bachmann, Huland, Steuber, Graefen, Schlomm, Minner, Sauter, Sirma, Simon: "CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer." in: Cancer research, Vol. 73, Issue 9, pp. 2795-805, (2013) (PubMed).

Liu, Lindberg, Sui, Luo, Egevad, Li, Xie, Wan, Kim, Wang, Turner, Zhang, Feng, Yan, Sun, Bova, Ewing, Yan, Gielzak, Cramer, Vessella, Zheng, Grönberg, Isaacs, Xu: "Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer." in: Oncogene, Vol. 31, Issue 35, pp. 3939-48, (2012) (PubMed).

Huang, Gulzar, Salari, Lapointe, Brooks, Pollack: "Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness." in: Oncogene, Vol. 31, Issue 37, pp. 4164-70, (2012) (PubMed).

Gallastegui, Millán-Zambrano, Terme, Chávez, Jordan: "Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency." in: Journal of virology, Vol. 85, Issue 7, pp. 3187-202, (2011) (PubMed).

Tao, Liu, Briones, Geiman, Muegge: "Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS." in: Nucleic acids research, Vol. 39, Issue 22, pp. 9508-20, (2011) (PubMed).

Yoshimura, Harada, Odawara, Azuma, Okada, Nakamura, Ohkawa, Tachibana: "Rat monoclonal antibody specific for the chromatin remodeling factor, CHD1." in: Hybridoma (2005), Vol. 29, Issue 3, pp. 237-40, (2010) (PubMed).

Tao, Xi, Briones, Muegge: "Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation." in: PLoS ONE, Vol. 5, Issue 2, pp. e9163, (2010) (PubMed).

Eissenberg, Lee, Schneider, Ilvarsonn, Shiekhattar, Shilatifard: "The trithorax-group gene in Drosophila little imaginal discs encodes a trimethylated histone H3 Lys4 demethylase." in: Nature structural & molecular biology, Vol. 14, Issue 4, pp. 344-6, (2007) (PubMed).

Cheng, Tan, Ganesan, Drake: "Integrating phosphoproteomics into the clinical management of prostate cancer." in: Clinical and translational medicine, Vol. 6, Issue 1, pp. 9 (PubMed).

Synonyms and alternative names related to CHD1

chromodomain helicase DNA binding protein 1 (CHD1), Chromodomain-helicase-DNA-binding protein (CHD1), chromodomain helicase DNA binding protein 1 (Chd1), Chromodomain-helicase-DNA-binding protein 1 (Chd1), chromodomain helicase DNA binding protein 1 (CHDB1), 4930525N21Rik, AI851787, AW555109, CG3733, CHD-1, CHD1, chd1, CHD1W, dCHD1, DmCHD1, Dmel\\CG3733, l(2)23Cd

Protein level used designations for CHD1

  • ATP-dependent helicase CHD1
  • CHD-1
  • chromodomain-helicase-DNA-binding protein 1
  • chromo-helicase/ATPase-DNA binding protein 1
  • chromodomain helicase DNA binding protein 1
  • CG3733-PA
  • CG3733-PB
  • CG3733-PC
  • Chd1-PA
  • Chd1-PB
  • Chd1-PC
  • Chromodomain-helicase-DNA-binding protein
  • chromo-ATPase/helicase-DNA-binding domain
  • chromo-ATPase/helicase-DNA-binding protein 1
  • lethal (2) 23Cd
  • LOW QUALITY PROTEIN: chromodomain-helicase-DNA-binding protein 1
You are here:
Support